{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T04:46:20Z","timestamp":1777956380273,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA0918000"],"award-info":[{"award-number":["2024YFA0918000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22238001, 22378016, 22478023"],"award-info":[{"award-number":["22238001, 22378016, 22478023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11380-7","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:40:06Z","timestamp":1761831606000},"page":"2447-2464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Deep learning-driven QSAR and micro-scale MD simulation-guided strategy reveals non-toxic human HGFR inhibitors"],"prefix":"10.1007","volume":"30","author":[{"given":"Muhammad Waleed","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ali","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qipeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"16","key":"11380_CR1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray F et al (2021) The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127(16):3029\u20133030","journal-title":"Cancer"},{"key":"11380_CR2","unstructured":"Cause G, and Age S (2020) by Country and by Region, 2000\u20132019. World Health Organization."},{"key":"11380_CR3","doi-asserted-by":"publisher","first-page":"1361601","DOI":"10.3389\/fmolb.2024.1361601","volume":"11","author":"M Bhadra","year":"2024","unstructured":"Bhadra M, Sachan M, Nara S (2024) Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool. Front Mol Biosci 11:1361601","journal-title":"Front Mol Biosci"},{"key":"11380_CR4","first-page":"649","volume-title":"Gynecologic Pathology","author":"N Singh","year":"2024","unstructured":"Singh N (2024) WHO classification of tumors of the ovary, pathology of the ovary. Gynecologic Pathology. Springer, New York, pp 649\u2013652"},{"key":"11380_CR5","doi-asserted-by":"crossref","unstructured":"Stewart C, Ralyea C, and Lockwood S (2019) Ovarian cancer: an integrated review. in Seminars in oncology nursing. Elsevier","DOI":"10.1016\/j.soncn.2019.02.001"},{"issue":"10","key":"11380_CR6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1200\/JOP.2016.016261","volume":"12","author":"KAP Schultz","year":"2016","unstructured":"Schultz KAP et al (2016) Ovarian sex cord-stromal tumors. J Oncol Pract 12(10):940\u2013946","journal-title":"J Oncol Pract"},{"issue":"9","key":"11380_CR7","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/cancers14092230","volume":"14","author":"J Huang","year":"2022","unstructured":"Huang J et al (2022) Worldwide burden, risk factors, and temporal trends of ovarian cancer: a global study. Cancers 14(9):2230","journal-title":"Cancers"},{"key":"11380_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2021.08.011","volume":"77","author":"C Marchetti","year":"2021","unstructured":"Marchetti C et al (2021) Chemotherapy resistance in epithelial ovarian cancer: mechanisms and emerging treatments. Semin Cancer Biol 77:144\u2013166","journal-title":"Semin Cancer Biol"},{"issue":"10177","key":"11380_CR9","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S et al (2019) Epithelial ovarian cancer. Lancet 393(10177):1240\u20131253","journal-title":"Lancet"},{"issue":"2","key":"11380_CR10","first-page":"139","volume":"22","author":"Y-X Wang","year":"2021","unstructured":"Wang Y-X et al (2021) The emerging roles of extracellular vesicles in ovarian cancer. Curr Drug Metab 22(2):139\u2013149","journal-title":"Curr Drug Metab"},{"key":"11380_CR11","doi-asserted-by":"publisher","first-page":"4936","DOI":"10.1007\/s00261-021-03163-z","volume":"46","author":"F Yao","year":"2021","unstructured":"Yao F et al (2021) Ultrasound-based radiomics score: a potential biomarker for the prediction of progression-free survival in ovarian epithelial cancer. Abdom Radiol 46:4936\u20134945","journal-title":"Abdom Radiol"},{"issue":"5","key":"11380_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/medicina58050649","volume":"58","author":"HJ Kim","year":"2022","unstructured":"Kim HJ (2022) Therapeutic strategies for ovarian cancer in point of HGF\/c-MET targeting. Medicina (Kaunas) 58(5):649","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"11380_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s43094-024-00688-0","volume":"10","author":"SA Dhawale","year":"2024","unstructured":"Dhawale SA et al (2024) Exploring the potential of small molecules of dual c-Met and VEGFR inhibitors for advances and future drug discovery in cancer therapy. Future J Pharm Sci 10(1):127","journal-title":"Future J Pharm Sci"},{"key":"11380_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ejca.2017.06.018","volume":"83","author":"IB Vergote","year":"2017","unstructured":"Vergote IB et al (2017) A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma. Eur J Cancer 83:229\u2013236","journal-title":"Eur J Cancer"},{"issue":"9","key":"11380_CR15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1158\/1541-7786.MCR-23-0680","volume":"22","author":"JM Santiago-O\u2019Farrill","year":"2024","unstructured":"Santiago-O\u2019Farrill JM et al (2024) Crizotinib enhances PARP inhibitor efficacy in ovarian cancer cells and xenograft models by inducing autophagy. Mol Cancer Res 22(9):840\u2013851","journal-title":"Mol Cancer Res"},{"issue":"12","key":"11380_CR16","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1158\/1078-0432.CCR-10-3387","volume":"17","author":"M Zillhardt","year":"2011","unstructured":"Zillhardt M et al (2011) Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis. Clin Cancer Res 17(12):4042\u20134051","journal-title":"Clin Cancer Res"},{"issue":"D1","key":"11380_CR17","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40(D1):D1100\u2013D1107","journal-title":"Nucleic Acids Res"},{"issue":"31.10","key":"11380_CR18","first-page":"5281","volume":"8","author":"G Landrum","year":"2013","unstructured":"Landrum G (2013) RDKit: a software suite for cheminformatics, computational chemistry, and predictive modeling. Greg Landrum 8(31.10):5281","journal-title":"Greg Landrum"},{"issue":"9","key":"11380_CR19","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1089\/cmb.2019.0323","volume":"27","author":"X Chen","year":"2020","unstructured":"Chen X et al (2020) Analysis of the physicochemical properties of acaricides based on Lipinski\u2019s rule of five. J Comput Biol 27(9):1397\u20131406","journal-title":"J Comput Biol"},{"issue":"3","key":"11380_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/cmdc.200700139","volume":"3","author":"R Brenk","year":"2008","unstructured":"Brenk R et al (2008) Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem 3(3):435\u2013444","journal-title":"ChemMedChem"},{"key":"11380_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ymeth.2014.08.005","volume":"71","author":"A Cereto-Massagu\u00e9","year":"2015","unstructured":"Cereto-Massagu\u00e9 A et al (2015) Molecular fingerprint similarity search in virtual screening. Methods 71:58\u201363","journal-title":"Methods"},{"issue":"5","key":"11380_CR22","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0731-7085(99)00272-1","volume":"22","author":"S Agatonovic-Kustrin","year":"2000","unstructured":"Agatonovic-Kustrin S, Beresford R (2000) Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J Pharm Biomed Anal 22(5):717\u2013727","journal-title":"J Pharm Biomed Anal"},{"key":"11380_CR23","doi-asserted-by":"crossref","unstructured":"Joseph FJJ, Nonsiri S, and Monsakul A (2021) Keras and TensorFlow: A hands-on experience. Advanced deep learning for engineers and scientists: A practical approach 85\u2013111","DOI":"10.1007\/978-3-030-66519-7_4"},{"issue":"1","key":"11380_CR24","first-page":"1525","volume":"7","author":"T Chai","year":"2014","unstructured":"Chai T, Draxler RR (2014) Root mean square error (RMSE) or mean absolute error (MAE). Geosci Model dev Discuss 7(1):1525\u20131534","journal-title":"Geosci Model dev Discuss"},{"issue":"D1","key":"11380_CR25","doi-asserted-by":"publisher","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","volume":"52","author":"C Knox","year":"2024","unstructured":"Knox C et al (2024) DrugBank 6.0: the DrugBank knowledgebase for 2024. Nucleic Acids Res 52(D1):D1265\u2013D1275","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"11380_CR26","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","volume":"60","author":"JJ Irwin","year":"2020","unstructured":"Irwin JJ et al (2020) ZINC20\u2014a free ultralarge-scale chemical database for ligand discovery. J Chem Inf Model 60(12):6065\u20136073","journal-title":"J Chem Inf Model"},{"issue":"D1","key":"11380_CR27","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim S et al (2023) PubChem 2023 update. Nucleic Acids Res 51(D1):D1373\u2013D1380","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"11380_CR28","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2174\/156802608786786624","volume":"8","author":"S Vilar","year":"2008","unstructured":"Vilar S, Cozza G, Moro S (2008) Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem 8(18):1555\u20131572","journal-title":"Curr Top Med Chem"},{"key":"11380_CR29","unstructured":"DeLano, W.L., (2002) Pymol: An open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr 40(1): 82\u201392."},{"key":"11380_CR30","unstructured":"Jejurikar BL and Rohane SH (2021) Drug designing in discovery studio."},{"issue":"2","key":"11380_CR31","first-page":"198","volume":"3","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, Case DA, Walker RC (2013) An overview of the Amber biomolecular simulation package. Wiley Interdiscip Rev: Comput Mol Sci 3(2):198\u2013210","journal-title":"Wiley Interdiscip Rev: Comput Mol Sci"},{"key":"11380_CR32","doi-asserted-by":"publisher","first-page":"120116","DOI":"10.1016\/j.molliq.2022.120116","volume":"365","author":"Q Ke","year":"2022","unstructured":"Ke Q et al (2022) Effects of thermostats\/barostats on physical properties of liquids by molecular dynamics simulations. J Mol Liq 365:120116","journal-title":"J Mol Liq"},{"issue":"5","key":"11380_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","volume":"22","author":"V Kr\u00e4utler","year":"2001","unstructured":"Kr\u00e4utler V, Van Gunsteren WF, H\u00fcnenberger PH (2001) A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J Comput Chem 22(5):501\u2013508","journal-title":"J Comput Chem"},{"issue":"1","key":"11380_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1021\/acs.jcim.3c01250","volume":"64","author":"E Heid","year":"2023","unstructured":"Heid E et al (2023) Chemprop: a machine learning package for chemical property prediction. J Chem Inf Model 64(1):9\u201317","journal-title":"J Chem Inf Model"},{"issue":"2","key":"11380_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1039\/C7SC02664A","volume":"9","author":"Z Wu","year":"2018","unstructured":"Wu Z et al (2018) MoleculeNet: a benchmark for molecular machine learning. Chem Sci 9(2):513\u2013530","journal-title":"Chem Sci"},{"issue":"11","key":"11380_CR36","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1021\/ci8001556","volume":"48","author":"RD Cramer","year":"2008","unstructured":"Cramer RD et al (2008) Virtual screening for R-groups, including predicted pIC50 contributions, within large structural databases, using Topomer CoMFA. J Chem Inf Model 48(11):2180\u20132195","journal-title":"J Chem Inf Model"},{"key":"11380_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00210-001-0521-y","volume":"365","author":"P Hannaert","year":"2002","unstructured":"Hannaert P et al (2002) Rat NKCC2\/NKCC1 cotransporter selectivity for loop diuretic drugs. Naunyn-Schmiedebergs Arch Pharmacol 365:193\u2013199","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"11380_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/molecules22010136","volume":"22","author":"A Castro-Alvarez","year":"2017","unstructured":"Castro-Alvarez A, Costa AM, Vilarrasa J (2017) The performance of several docking programs at reproducing protein\u2013macrolide-like crystal structures. Molecules 22(1):136","journal-title":"Molecules"},{"issue":"2","key":"11380_CR39","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1158\/1078-0432.CCR-17-1606","volume":"24","author":"TL Lochmann","year":"2018","unstructured":"Lochmann TL et al (2018) Venetoclax is effective in small-cell lung cancers with high BCL-2 expression. Clin Cancer Res 24(2):360\u2013369","journal-title":"Clin Cancer Res"},{"issue":"2","key":"11380_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/antibiotics9020077","volume":"9","author":"M-J Sheu","year":"2020","unstructured":"Sheu M-J et al (2020) In vitro antimicrobial activity of various cefoperazone\/sulbactam products. Antibiotics 9(2):77","journal-title":"Antibiotics"},{"issue":"5","key":"11380_CR41","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1021\/acs.jcim.2c01444","volume":"63","author":"Y Maruyama","year":"2023","unstructured":"Maruyama Y et al (2023) Analysis of protein folding simulation with moving root mean square deviation. J Chem Inf Model 63(5):1529\u20131541","journal-title":"J Chem Inf Model"},{"key":"11380_CR42","doi-asserted-by":"crossref","unstructured":"Shukla R. and Tripathi T (2020) Molecular dynamics simulation of protein and protein\u2013ligand complexes. Computer-aided drug design 133\u2013161","DOI":"10.1007\/978-981-15-6815-2_7"},{"key":"11380_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov MY, Bogatyreva N, Galzitskaya O (2008) Radius of gyration as an indicator of protein structure compactness. Mol Biol 42:623\u2013628","journal-title":"Mol Biol"},{"issue":"1","key":"11380_CR44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jmb.2008.10.018","volume":"385","author":"GG Maisuradze","year":"2009","unstructured":"Maisuradze GG, Liwo A, Scheraga HA (2009) Principal component analysis for protein folding dynamics. J Mol Biol 385(1):312\u2013329","journal-title":"J Mol Biol"},{"issue":"9","key":"11380_CR45","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/cbic.202000695","volume":"22","author":"AS Abdelsattar","year":"2021","unstructured":"Abdelsattar AS, Mansour Y, Aboul-Ela F (2021) The perturbed Free-Energy landscape: linking ligand binding to biomolecular folding. ChemBioChem 22(9):1499\u20131516","journal-title":"ChemBioChem"},{"issue":"1","key":"11380_CR46","first-page":"84","volume":"14","author":"IJ dos Santos Nascimento","year":"2022","unstructured":"dos Santos Nascimento IJ et al (2022) Dynamic cross-correlation matrix (DCCM) reveals new insights to discover new NLRP3 inhibitors useful as anti-inflammatory drugs. Med Sci Forum 14(1):84","journal-title":"Med Sci Forum"},{"issue":"5","key":"11380_CR47","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U (2015) The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 10(5):449\u2013461","journal-title":"Expert Opin Drug Discov"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11380-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11380-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11380-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:03:46Z","timestamp":1777946626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11380-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["11380"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11380-7","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"14 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}